Stocks that traded heavily or had substantial price changes on Monday: Macy’s, United Rentals rise; Apple, Spirit Airlines fall
Akero's lead therapy fell short of its goals in a phase 2b trial to treat NASH.
What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...
Stocks that traded heavily or had substantial price changes on Tuesday: PepsiCo, Palantir rise; Neogen, Akero Therapeutics fall
So-so trial data for a competitor's NASH therapy candidate that is similar to 89bio's candidate spooked investors.
Investors are bailing on the biotech stock after disappointing clinical results for experimental NASH drug efruxifermin (EFX).
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.71%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.83%. Stocks...
Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are up +0.05%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are up +0.04%. Stock index futures this morning are slightly higher on the prospects...
December S&P 500 futures (ESZ23) are up +0.20%, and December Nasdaq 100 E-Mini futures (NQZ23) are up +0.26% this morning as comments from Fed officials bolstered bets that the U.S. central bank may stand...
Here are three mid-cap stocks that will not have been on the radar for most readers but whose recent performance warrants closer inspection and consideration.